Latest News and Blogs

Congenica's response to the UK Government's national genomic healthcare strategy, setting out its vision to extend the UK’s leadership in genomics

Congenica's new module accelerates research into the relationship between an individual’s genomic variation & COVID-19 susceptibility & clinical outcomes.

Congenica launches an update that will provide automated classification, evidence and reporting of recurrent ‘known’ variants, significantly saving time.

Congenica launches Congenica Prenatal, a new application that facilitate faster, more accurate and comprehensive molecular research into fetal anomalies.

Genomics England has announced a major new sequencing project to uncover how a person’s genetic make-up influences their susceptibility to COVID-19.

With case loads increasing every day, clinical teams are experiencing increasing pressure to make their variant interpretation more efficient.

Our Response To Coronavirus COVID-19 - Congenica

Whole Genome Sequencing at scale: experiences from a national genome sequencing project

RARE Bears bring community together on Rare Disease Day

Congenica today announced the launch of Congenica Neuro, a new application to enable faster analysis of epilepsy and neurodevelopmental disorders.

Congenica announced the publication of a study on the re-annotation of developmental & epileptic encephalopathy-associated genes with significant clinical implications.

Congenica platform provides variant review and assessment to support conclusive diagnoses for patients with complex and commonly misdiagnosed bleeding disorders.